It means Pfizer's core inline business is collapsing and drug launches are becoming a bust. The beast needs to feed on another big deal to message earnings.
Here's your 8k http://www.theguardian.com/business/2014/may/16/pfizer-executives-cashed-in-shares-bid-astrazeneca